FDA Grants Orphan and Pediatric Designations to NEU-001 for Hirschsprung’s Disease Neurenati Therapeutics Inc., a biotechnology company dedicated to pediatric rare diseases, is excited to announce that the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug and…
TEVIMBRA Approved in U.S. for Advanced Esophageal Cancer with Chemotherapy BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company set to change its name to BeOne Medicines Ltd., today announced that the U.S. Food and Drug Administration…
Centauri Therapeutics Selects First Clinical Candidate for Gram-Negative Infection Treatment Centauri Therapeutics Limited, an immunotherapy company leveraging its unique Alphamer® platform technology, has announced the selection of its first clinical candidate in the ABX-01 program. This groundbreaking compound is designed…
Sofinnova Partners Raises €1.2 Billion to Drive Life Sciences Innovation Sofinnova Partners, a leading European venture capital firm specializing in life sciences, has announced the successful raising of €1.2 billion over the past year across its diverse investment strategies. This…
SFI Health™ Launches Equazen® Supplements in Portugal for Cognitive Support SFI Health™ EMEA, the regional arm of SFI Health™, a global leader in natural healthcare, is excited to announce the upcoming launch of Equazen® products in Portugal. SFI Health™ is…
Children’s of Alabama Completes 150+ Sedation-Free TNEs Using EvoEndo System EvoEndo®, Inc. (EvoEndo) is proud to announce that Children’s of Alabama has successfully completed over 150 Sedation-Free Transnasal Endoscopies (TNEs) using the EvoEndo® Single-Use Endoscopy System. This makes Children’s of…
Osivax Secures Funding to Advance Influenza Vaccine Development Osivax, a biopharmaceutical company focused on developing vaccines for broad-spectrum protection against rapidly mutating respiratory viruses, has announced the successful first close of its Series B funding round, securing €10 million from…
Actio Biosciences Doses First Participant in Phase 1 Trial of ABS-0871 for CMT2C Actio Biosciences, a clinical-stage biotechnology company focused on using its “one to many” paradigm in genetics and precision medicine, has announced that the first participant has been…
Talkdesk AI Agents Enhance Healthcare Patient and Member Experience Talkdesk®, Inc., a global leader in artificial intelligence (AI)-powered customer experience (CX) technology, is empowering healthcare organizations to deliver a new level of integrated self-service. Their innovative solution, Talkdesk AI Agents…
SOTIO Reveals Promising Preclinical Data on SOT109 for Colorectal Cancer SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, has unveiled groundbreaking preclinical data for SOT109, a novel antibody-drug conjugate (ADC) designed to target cadherin-17 (CDH17). The data, presented…
Lightbeam Health to Showcase AI Solution Transforming Patient Outcomes at HIMSS 2025 Lightbeam Health Solutions, a leader in population health technology, will be an exhibiting sponsor at HIMSS25, held from March 3-6, 2025, in Las Vegas, NV. Attendees are invited…
Elucid Appoints Clinical and Commercial Leaders Before PlaqueIQ™ Launch Elucid, an AI-driven medical technology company specializing in providing physicians with a more accurate view of atherosclerosis for tailored treatment decisions, has strengthened its clinical and commercial teams with several senior…
